(1)
Shabbir, A.; Yumn, L.; Khan, E. Mavacamten’s Therapeutic Impact: Cardiac-Specific Myosin Inhibition in Obstructive Hypertrophic Cardiomyopathy. Global Cardiol 2024, 2.